{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:59:40Z","timestamp":1785373180893,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perivascular epitheloid cell tumor (PEComas) are characterized by expression of both muscles, most often smooth muscle actin (in ~80% of cases) and melanocytic markers (mainly HMB-45 and Melan A). TFE 3-associated PEComas are new variant which are poorly defined due to their limited reports in literature. These tumors lack response to targeted mTOR inhibitor therapy due to lack of mutation in TSC gene. Hereby, we are reporting a case of TFE3 associated pelvic PEComa showing excellent response to Everolimus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 45-year-old female presented with complaint of abdominal mass and bleeding per vaginum for 4 months. She had a history of total abdominal hysterectomy 3 years back in view of abnormal uterine bleeding and exploratory laprotomy 7 months back to remove some pelvic mass. Imaging suggested of ill-defined heterogenous mass of 9.3 x 9.2 x 16 cm involving the uterus, cervix, and upper 1\/3 vagina. Multiple omental and peritoneal deposits were also seen, making probable diagnosis of carcinoma endometrium. USG guided biopsy showed cores of fibrous tissue with the presence of cells in sheets with granular eosinophillic cytoplasm; IHC showed positivity for TFE-3, H Caldesmon, GATA-3, and Melan A- and HMB-45; and Ki 67 index was 35%. The basis of above diagnosis of PEComa was made and she was started on Everolimus; repeat imaging after 3 months of therapy showed complete response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We are reporting first case of malignant pelvic TFE 3 PEComa showing response to mTOR therapy. Identification of TFE 3 PEComa is important because they showed different biologic behavior then their conventional PEComa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-021-02462-5","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T01:24:53Z","timestamp":1646097893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-239X","authenticated-orcid":false,"given":"Roli","family":"Purwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridula","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"2462_CR1","volume-title":"International academy of pathology: pathology and genetics of tumours of soft tissue and bone","author":"CDM Fletcher","year":"2002","unstructured":"Fletcher CDM, Unni KK, Mertens F, et al. International academy of pathology: pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002."},{"key":"2462_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.crad.2012.10.021","volume":"68","author":"Y Tan","year":"2013","unstructured":"Tan Y, Zhang H, Xiao EH. Perivascular epithelioid cell tumour: dynamic CT, MRI and clinicopathological characteristics analysis of 32 cases and review of the literature. Clin Radiol. 2013;68:555\u201361.","journal-title":"Clin Radiol"},{"issue":"12","key":"2462_CR3","first-page":"4380","volume":"12","author":"L Bao","year":"2019","unstructured":"Bao L, Shi Y, Zhong J, Zhao M, Wu J, Hai L, et al. Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa). Int J Clin Exp Pathol. 2019;12(12):4380\u20139 PMID: 31933841; PMCID: PMC6949869.","journal-title":"Int J Clin Exp Pathol"},{"key":"2462_CR4","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558\u201375.","journal-title":"Am J Surg Pathol"},{"key":"2462_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","volume":"39","author":"JK Schoolmeester","year":"2015","unstructured":"Schoolmeester JK, Dao LN, Sukov WR, Wang L, Park KJ, Murali R, et al. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis. Am J Surg Pathol. 2015;39:394\u2013404.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2462_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","volume":"42","author":"JA Bennett","year":"2018","unstructured":"Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, et al. Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors. Am J Surg Pathol. 2018;42(10):1370\u201383. https:\/\/doi.org\/10.1097\/PAS.0000000000001119 PMID: 30001237; PMCID: PMC6133752.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"2462_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00404-018-4920-4","volume":"299","author":"W Shan","year":"2019","unstructured":"Shan W, Shi Y, Zhu Q, Yang B, Xie L, Li B, et al. Five cases of uterine perivascular ep ithelioid cell tumors (PEComas) and review of literature. Arch Gynecol Obstet. 2019;299(1):185\u201390. https:\/\/doi.org\/10.1007\/s00404-018-4920-4 Epub 2018 Oct 13. PMID: 30317387.","journal-title":"Arch Gynecol Obstet."},{"issue":"6","key":"2462_CR8","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/j.clgc.2020.04.004","volume":"18","author":"M Vannucchi","year":"2020","unstructured":"Vannucchi M, Minervini A, Salvi M, Montironi R, Raspollini MR. TFE3 gene rearrangement in perivascular epithelioid cell neoplasm (PEComa) of the genitourinary tract. Clin Genitourin Cancer. 2020;18(6):e692\u20137. https:\/\/doi.org\/10.1016\/j.clgc.2020.04.004 Epub 2020 May 15. PMID: 32576448.","journal-title":"Clin Genitourin Cancer."},{"issue":"5","key":"2462_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00428-014-1655-x","volume":"465","author":"Q Shen","year":"2014","unstructured":"Shen Q, Rao Q, Xia QY, Yu B, Shi QL, Zhang RS, et al. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch. 2014;465(5):607\u201313. https:\/\/doi.org\/10.1007\/s00428-014-1655-x Epub 2014 Sep 20. PMID: 25239799.","journal-title":"Virchows Arch."},{"issue":"2","key":"2462_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.path.2019.01.004","volume":"12","author":"C Parra-Herran","year":"2019","unstructured":"Parra-Herran C, Howitt BE. Uterine mesenchymal tumors: update on classification, staging, and molecular features. Surg Pathol Clin. 2019;12(2):363\u201396. https:\/\/doi.org\/10.1016\/j.path.2019.01.004 PMID: 31097109.","journal-title":"Surg Pathol Clin."},{"issue":"8","key":"2462_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/diagnostics10080553","volume":"10","author":"L Giannella","year":"2020","unstructured":"Giannella L, Delli Carpini G, Montik N, Verdecchia V, Puccio F, Di Giuseppe J, et al. Ultrasound features of a uterine perivascular epithelioid cell tumor (PEComa): case report and literature review. Diagnostics (Basel). 2020;10(8):553. https:\/\/doi.org\/10.3390\/diagnostics10080553 PMID: 32756336; PMCID: PMC7459969.","journal-title":"Diagnostics (Basel)."},{"key":"2462_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature03664","volume":"436","author":"LA Garraway","year":"2005","unstructured":"Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117\u201322.","journal-title":"Nature"},{"key":"2462_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2559.2008.03057.x","volume":"53","author":"HY Cho","year":"2008","unstructured":"Cho HY, Chung DH, Khurana H, et al. The role of TFE3 in PEComa. Histopathology. 2008;53:236\u201349 [PubMed: 18510571].","journal-title":"Histopathology."},{"key":"2462_CR14","first-page":"6409","volume":"7","author":"F Liu","year":"2014","unstructured":"Liu F, Zhang R, Wang ZY, et al. Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report. Int J Clin Exp Pathol. 2014;7:6409\u201314 [PubMed: 25337301].","journal-title":"Int J Clin Exp Pathol."},{"key":"2462_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4132\/jptm.2016.04.20","volume":"50","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Hong JH, Kim A, et al. A case of malignant PEComa of the uterus associated with intramural leiomyoma and endometrial carcinoma. J Pathol Transl Med. 2016;50:469\u201373 [PubMed: 27452081].","journal-title":"J Pathol Transl Med."},{"issue":"3","key":"2462_CR16","first-page":"543","volume":"13","author":"Y Hu","year":"2020","unstructured":"Hu Y, Wang L, Shi H, Hu B. Endometrial polyp-like perivascular epithelioid cell neoplasm associated with TFE3 translocation: report of one case. Int J Clin Exp Pathol. 2020;13(3):543\u20139 PMID: 32269693; PMCID: PMC7137019.","journal-title":"Int J Clin Exp Pathol"},{"key":"2462_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2015.05.002","volume":"19","author":"A Musella","year":"2015","unstructured":"Musella A, De Felice F, Kyriacou AK, Barletta F, Di Matteo FM, Marchetti C, et al. Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review. Int J Surg. 2015;19:1\u20135. https:\/\/doi.org\/10.1016\/j.ijsu.2015.05.002 Epub 2015 May 14. PMID: 25981307.","journal-title":"Int J Surg."},{"key":"2462_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.582087","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Gong XL, Wu H, Zhao L. Case report: gastrointestinal PEComa with TFE3 rearrangement treated with anti-VEGFR TKI apatinib. Front Oncol. 2020;10:582087. https:\/\/doi.org\/10.3389\/fonc.2020.582087 PMID: 33330059; PMCID: PMC7719820.","journal-title":"Front Oncol."},{"issue":"2","key":"2462_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000477434","volume":"10","author":"RJ Lin","year":"2017","unstructured":"Lin RJ, Melamed J, Wu J. PEComa with transcription factor E3 overexpression: a diagnostic and therapeutic challenge. Case Rep Oncol. 2017;10(2):531\u20133. https:\/\/doi.org\/10.1159\/000477434 PMID: 28690528; PMCID: PMC5498957.","journal-title":"Case Rep Oncol."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02462-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T01:28:22Z","timestamp":1646098102000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02462-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02462-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-915540\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not required as patient consent for publication was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written consent for publication of case report and accompanied images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}